drugset / Trial / NCT03180450
The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF)
RandomizedParallel-groupOpen-labelTreatment
Summary
The purposes of the study is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells (hUC-MSC) in treating heart failure patients
Timeline
- Start
- 2025-12-31
- Primary completion
- 2026-06-30
- Completion
- 2026-12-31
Outcome
Outcome not reported
Stopped: “Others”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allogeneic umbilical cord mesenchymal stem cells | Cell therapy | — | Intravenous |
| Background | Furosemide | Other / unclassified | — | — |
| Background | Milrinone | Small molecule | — | — |